Response to: lower‐dose valganciclovir for prevention of cytomegalovirus after solid organ transplant: an important tradeoff

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 4, 2015-08 ,pp. : 625-626

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of breakthrough infection among cytomegalovirus donor‐positive/recipient‐negative kidney transplant recipients receiving lower‐dose valganciclovir prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 163-173

John Wiley & Sons Inc

Access to resources Recommend Favorite

Factors associated with the development of cytomegalovirus infection following solid organ transplantation

By da Cunha-Bang Caspar   Søørensen Søøren S.   Iversen Martin   Sengeløøv Henrik   Hillingsøø Jens G.   Rasmussen Allan   Mortensen Svend A.   Fox Zoe V.   Kirkby Nikolai S.   Christiansen Claus B.   Lundgren Jens D.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 5, 2011-05 ,pp. : 360-365

Informa Healthcare

Access to resources Recommend Favorite

Significance of Qualitative Polymerase Chain Reaction Combined with Quantitation of Viral Load in the Diagnosis and Follow-Up of Cytomegalovirus Infection after Solid-Organ Transplantation

By  

Intervirology, Vol. 42, Iss. 5-6, 2000-02 ,pp. : 398-404

Karger

Access to resources Recommend Favorite

Overcoming the Problem of Cytomegalovirus Infection after Organ Transplantation: Calling for Heracles?

By  

Intervirology, Vol. 42, Iss. 5-6, 2000-02 ,pp. : 285-290

Karger

Access to resources Recommend Favorite